Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Chimeric Therapeutics Ltd. is set to hold an Extraordinary General Meeting on December 4, 2024, both in-person and online, offering shareholders the chance to engage actively in the company’s strategic discussions. This meeting presents an opportunity for investors to stay informed and potentially influence the company’s future directions. Shareholders can participate virtually via a webcast or submit their votes using a proxy form.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.